University of Colorado Campuses and Medtronic forge strategic research agreement to drive health care innovation

The University of Colorado and Medtronic, a global health care technology company, today announced a strategic research agreement to accelerate the development of novel health technologies. The University of Colorado (CU) was selected from a nationwide search for academic institutions positioned to lead the future of healthcare innovation.

This agreement marks the second academic strategic partnership established by Medtronic. Designed to be a long-term collaboration, the partnership aims to address disruptive areas in health care- such as AI, robotics, sustainability, and advanced materials- to drive breakthrough solutions that advance healthcare.

Together, Medtronic and the CU campuses aim to deliver technologies that move from lab to bedside faster- bringing real benefits to patients and advancing global health. The partnership was formally launched at a joint summit on the CU Anschutz campus, where priority research projects and initiatives for advancement were identified.

"We are thrilled to welcome the University of Colorado as our newest academic strategic research partner," said Jim Peichel, Chief Technology Officer at Medtronic. "Together, we will explore new frontiers that are critical to the future of healthcare and to the Medtronic Mission of alleviating pain, restoring health and extending life."

This unique collaboration will span across CU Anschutz, CU Boulder and CU Denver, harnessing the diverse expertise and innovation strengths of each campus to address some of the most pressing health challenges today. The collaboration will initially focus on three transformative areas aligned to the Medtronic global technology strategy: sustainability, robotics and artificial intelligence.

"This agreement represents a bold step forward in how academic institutions and industry leaders can work together to drive meaningful innovation," said Kim Muller, Executive Director of CU Anschutz Innovations. "By leveraging the strengths of our campuses and aligning with the Medtronic mission, we are creating a powerful platform for discovery and impact."

CU Anschutz publishes an average of 3,000+ papers a year, with over 3,500 clinical trials underway. CU Anschutz Innovations serves as the medical campus's hub for innovation and entrepreneurship, connecting researchers, clinicians and industry partners to accelerate the development of groundbreaking healthcare solutions. Through IP and licensing support, strategic partnerships and commercialization resources, their team transforms academic discoveries into real-world applications that improve patient care and advance global health.

"This is an incredible collaboration across the breakthrough innovation ecosystem at CU Boulder, clinical excellence at CU Anschutz, and enhancements in patient care delivered by Medtronic," said Bryn Rees, associate vice chancellor for innovation and partnerships at CU Boulder. "We are excited to contribute to improving healthcare through this university-industry alliance."

"This initiative brings together CU Anschutz's strengths in health sciences research with industry insights to address key challenges in healthcare- from sustainability to robotics and data-driven innovation," said John H. Sampson, MD, PhD, MBA, University of Colorado Anschutz Vice Chancellor for Health Affairs and Dean, School of Medicine. "It's an exciting step toward our mission of bringing innovative technologies from the lab to the bedside, delivering real benefits to patients more swiftly and effectively."

This collaboration reflects the University of Colorado's continued leadership in research and innovation, and its dedication to fostering collaborative relationships that translate academic excellence into real-world solutions.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visitwww.Medtronic.com and follow on LinkedIn.

About University of Colorado Anschutz

The University of Colorado Anschutz is a world-class academic medical campus at the forefront of transformative science, medicine, education and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes and two nationally ranked independent hospitals - UCHealth University of Colorado Hospital and Children's Hospital Colorado - which see more nearly 3 million adult and pediatric patient visits yearly. Innovative, interconnected and highly collaborative, CU Anschutz delivers life-changing treatments, patient care and professional training and conducts world-renowned research fueled by $890 million in annual research funding, including $762 million in sponsored awards and $128 million in philanthropic gifts.

About University of Colorado Boulder

The University of Colorado Boulder is Colorado's leading public research university, transforming lives since 1876. As the state's flagship university and one of only 38 U.S. public research institutions in the Association of American Universities (AAU), CU Boulder has proudly served Coloradans since the state's founding. Home to five Nobel Laureates since 1989 and the only university to send space instruments to every planet in the solar system, CU Boulder provides a strong return on investment by aligning efforts to achieve research excellence, global sustainability impact and the success of all students, faculty and staff. Learn more at colorado.edu/about.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:

Kallie Knop, PR at University of Colorado
[email protected]
7046170582

Laura Hennen, PR at Medtronic
[email protected]
763-213-3034